Tag: Phase III

Definium Therapeutics’ LSD-Based Pill Delivers Second Phase III Success

by Psychedelics.Media Team

August 13, 2026

Definium Therapeutics has reported positive Phase III results for its LSD-based medicine DT120 in generalised anxiety disorder, giving the company ...

No Result

View All Result

Home
News
Business
Policy & Regulation
Research
Health & Therapy
Opinion
Contact

Not enough quota to unlock this post

Unlock left : 0

Tag: Phase III

Definium Therapeutics’ LSD-Based Pill Delivers Second Phase III Success

Newsletter

Stay Ahead of Psychedelic Medicine

Recommended

Inside the Psychedelic Mind: How Music, Imagery and Environment Could Shape the Future of Therapy

The Psychedelic Story Has Changed: 25 Years of Media Coverage Analysed

Popular Story

Incannex and the Next Test for Psychedelic Medicine

BLS Pharmaceuticals expands commercial leadership with new Strategic Partnership Director

The Global Psychedelic Medicine Conference & Events Calendar 2026–2027

Eli Lilly Reportedly Nears Acquisition of AtaiBeckley in Potential Landmark Deal for Psychedelic Medicine

AbbVie’s $906M Psychedelic Bet: What It Means for Psychedelic Medicine

Recent Posts

Categories

Free Weekly Newsletter

Not enough quota to unlock this post

Are you sure want to cancel subscription?